Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Nuclear Medicine

  Free Subscription


1 Am J Cardiol
1 Circ Cardiovasc Imaging
2 Hum Brain Mapp
1 J Cereb Blood Flow Metab
1 J Nucl Cardiol
4 J Nucl Med
2 Neurology
1 Nucl Med Commun

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. CHURCHILL R, Sykora D, Castrichini M, Arment C, et al
    Clinical Response to Tumor Necrosis Factor-alpha Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
    Am J Cardiol. 2023;205:20-27.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  2. DE WINTER RW, Jukema RA, van Diemen PA, Schumacher SP, et al
    Prognostic Value of Modified Coronary Flow Capacity Derived From [(15)O]H(2)O Positron Emission Tomography Perfusion Imaging.
    Circ Cardiovasc Imaging. 2023;16:e014845.
    PubMed         Abstract available

    Hum Brain Mapp

  3. SCHINZ D, Schmitz-Koep B, Zimmermann J, Brandes E, et al
    Indirect evidence for altered dopaminergic neurotransmission in very premature-born adults.
    Hum Brain Mapp. 2023;44:5125-5138.
    PubMed         Abstract available

  4. ZHANG Y, Li X, Ji Y, Ding H, et al
    MRAbeta: A multimodal MRI-derived amyloid-beta biomarker for Alzheimer's disease.
    Hum Brain Mapp. 2023;44:5139-5152.
    PubMed         Abstract available

    J Cereb Blood Flow Metab

  5. SCOTT MR, Edwards NC, Properzi MJ, Jacobs HI, et al
    Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal.
    J Cereb Blood Flow Metab. 2023 Sep 20:271678X231196978.
    PubMed         Abstract available

    J Nucl Cardiol

  6. LIMA BB, Benz DC
    Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
    J Nucl Cardiol. 2023 Sep 20. doi: 10.1007/s12350-023-03376.

    J Nucl Med

  7. SCHMIDKONZ C, Atzinger A, Ramming A, Kuwert T, et al
    FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders.
    J Nucl Med. 2023 Sep 21:jnumed.123.266182. doi: 10.2967/jnumed.123.266182.

  8. KLUGE K, Haberl D, Einspieler H, Rasul S, et al
    Antihormonal-Treatment Status Affects (68)Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.
    J Nucl Med. 2023 Sep 21:jnumed.123.265980. doi: 10.2967/jnumed.123.265980.
    PubMed         Abstract available

  9. ITTI E, Blanc-Durand P, Berriolo-Riedinger A, Kanoun S, et al
    Validation of the DeltaSUV(max) for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
    J Nucl Med. 2023 Sep 21:jnumed.123.265871. doi: 10.2967/jnumed.123.265871.
    PubMed         Abstract available

  10. DEMMERT TT, Pomykala KL, Lanzafame H, Pabst KM, et al
    Oncologic Staging with (68)Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than (18)F-FDG PET/CT.
    J Nucl Med. 2023 Sep 21:jnumed.123.265751. doi: 10.2967/jnumed.123.265751.
    PubMed         Abstract available


  11. DURCAN R, Roberts G, Hamilton CA, Donaghy PC, et al
    Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy Bodies, Alzheimer Disease, and Age-Matched Controls.
    Neurology. 2023 Jul 31:10.1212/WNL.0000000000207621.
    PubMed         Abstract available

  12. PROKOPIOU PC, Engels-Dominguez N, Schultz AP, Sepulcre J, et al
    Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.
    Neurology. 2023 Jul 25:10.1212/WNL.0000000000207646.
    PubMed         Abstract available

    Nucl Med Commun

  13. LUE KH, Chen YH, Chu SC, Chang BS, et al
    A comparison of 18F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study.
    Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001776.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.